Three ways to build a better population health team
Here are three things to consider when developing a population health management team at your organization.
Read More
Missing this data can hurt your population health strategies
Key socioeconomic data that will help you care for your most vulnerable populations.
Combination pack approved for breast cancer treatment
FDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.
Personalized medicine brings big wins to managed care
A new report reveals how personalized medicine can make patients healthier while lowering costs.
Why there’s an uptick in outcomes-based contracts
Operational issues aside, outcomes-based contracts can offer a two-fold benefit for managed care executives.
ACA exchanges: Who's in, who's out?
What MCOs should know about insurers’ plans for the marketplace exchanges in 2018.
Top 3 roadblocks to medication adherence and how to avoid them
Here are the top three reasons for medication adherence failure and how to overcome them.
Top 5 specialty drug management issues
The 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.
Four ways health execs can help their organizations mitigate cyberattacks
Healthcare executives are starting to realize that preventing cyberattacks is not just a task for their IT departments and third-party security vendors.
How pharma reps impact physician prescribing
A new study led by The University of California researchers and published in JAMA reveals surprising findings.
Can Amazon change the pharmacy landscape?
Industry experts analyze issues of mail delivery and transparency in the prescription drug market.
Amputation risk possible with diabetes drugs, FDA warns
Based on new data from 2 large clinical trials, FDA is warning that these blockbuster type 2 diabetes medications can cause an increased risk of leg and foot amputations.
FDA expands cystic fibrosis treatment
FDA expanded the use of ivacaftor (Kalydeco, Vertex Pharmaceuticals) to treat cystic fibrosis.
AHCA next steps: 4 things MCOs should know
What are the next steps for the bill, and how likely is it that it will become law? Here’s are four things MCOs should know.
Opinion: Biggest problems with single-payer ‘Medicare-for-all’
Our policy analyst explains why he believes single payer Medicare-for-all is a pipe dream.
Opinion: Top 2 takeaways from Asembia Specialty Pharmacy Summit
The conference raised important points about value-based contracts and the specialty pharmacy space.
Top ACA provisions employers want to keep
A Willis Towers Watson survey finds that employers see enhancing the employee experience in healthcare as key to boosting health engagement.
Use population health to fight substance abuse: Tips for MCOs
Find out how the American College of Physicians says population health data can decrease opioid addiction and abuse.
Physician shortages may affect population health strategies
By 2025, the United States could be facing a shortage ranging from 34,600 to 88,000 physicians in total. Find out how this could affect population health initiatives.
New FDA lead ushers in new era
Scott Gottlieb, MD, was sworn in as the new FDA commissioner and ushers in a new era.
Immuno-oncology bladder drug wins approval
Soon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.
Rising diabetes rates in children: Four things health execs should know
Here are four things MCOs should know about a new study focusing on young patients with diabetes.
Top 3 strategies employers should use to decrease healthcare costs
A new Willis Towers Watson survey finds that U.S. employers have three key strategies to building cost-effective healthcare programs.
Humana shares its population health management secrets
Humana’s goal is to improve the health of the communities it serves 20% by the year 2020. Find out how it is reaching this goal.
Robust multiple myeloma treatment program holds promise
The Medical College of Wisconsin’s multiple myeloma program is robust and growing.
Fourteen things Trump needs to know about opioids
As President Trump promises fight the opioid epidemic, here are 14 things experts want him to know.
Healthcare industry leaders share their favorite vacation spots
Ready to pack your bags for a little R&R? Here are a few favorite spots recommended by industry leaders.
Asian-American women need better targeted breast cancer therapy
A new study provides new insights into the epidemiology of breast cancer among the most prominent Asian-American ethnic groups in California.
Costly new ALS treatment approved
FDA recently approved the first new treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, in more than 20 years.
Campaign gears up to combat high drug prices
Walmart, CVS Health, and a number of other healthcare organizations are supporting a new multi-million dollar consumer campaign to combat high prescription drug prices.
